EmboMedics, Inc. — Form D
EmboMedics, Inc. of Minneapolis, MN, a company, filed a Form D exempt-offering notice with the SEC on 2014-08-14. The offering totals $5.0M, of which $847K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2014-08-14
- Form: D
- Accession: 0001181431-14-029189
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $847K
- Remaining: $4.2M
- Investors: 9
- Date of first sale: 2014-07-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-222927
Issuer
- Name: EmboMedics, Inc.
- CIK: 0001592901
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 678 Mendelssohn Ave. N., Minneapolis, MN, 55427
- Phone: 763-398-5120
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Kraig D Black | Director | Maple Grove, MN |
| Robert Cohen | Director | Eden Prairie, MN |
| Robert Cohen | Executive Officer | Eden Prairie, MN |
| Jon Freeman | Executive Officer | Santa Clara, CA |
| Reza Malek | Director | San Francisco, CA |
| Jafar Golzarian | Director | Minneapolis, MN |
| Jafar Golzarian | Executive Officer | Minneapolis, MN |
| Jafar Golzarian | Promoter | Minneapolis, MN |
| Robert Halverson | Director | Minneapolis, MN |
| Gerald D Van Eeckhout | Director | Minneapolis, MN |
| Lihui Weng | Executive Officer | Maple Grove, MN |
| Robert D Halverson | Director | Maple Grove, MN |
| Omid Souresrafil | Director | Maple Grove, MN |
| Omid Souresrafil | Executive Officer | Maple Grove, MN |
| Omid Souresrafil | Promoter | Maple Grove, MN |
Other filings by this issuer (3)
More